Patient characteristics
. | MM patient . | NHL patients . | All patients . |
|---|---|---|---|
| No. | 10 | 15 | 25 |
| Age, y | |||
| Mean/median | 61/63 | 56/59 | 58/60 |
| Minimum/maximum | 43/72 | 31/66 | 31/72 |
| Sex, no.(%) | |||
| Female | 3 (30.0) | 8 (53.3) | 11 (44.0) |
| Male | 7 (70.0) | 7 (46.7) | 14 (56.0) |
| Ethnic group, no. (%) | |||
| White | 5 (50.0) | 14 (93.3) | 19 (76.0) |
| African American | 4 (40.0) | 0 (0.0) | 4 (16.0) |
| Hispanic/Latino | 1 (10.0) | 1 (6.7) | 2 (8.0) |
| Prior treatment, median (range) | |||
| No. regimens | 1 (1-4) | 2 (1-5) | 2 (1-5) |
| Mo./no. cycles of treatment | 4 (3-15) | 9 (4-25) | 7 (3-25) |
. | MM patient . | NHL patients . | All patients . |
|---|---|---|---|
| No. | 10 | 15 | 25 |
| Age, y | |||
| Mean/median | 61/63 | 56/59 | 58/60 |
| Minimum/maximum | 43/72 | 31/66 | 31/72 |
| Sex, no.(%) | |||
| Female | 3 (30.0) | 8 (53.3) | 11 (44.0) |
| Male | 7 (70.0) | 7 (46.7) | 14 (56.0) |
| Ethnic group, no. (%) | |||
| White | 5 (50.0) | 14 (93.3) | 19 (76.0) |
| African American | 4 (40.0) | 0 (0.0) | 4 (16.0) |
| Hispanic/Latino | 1 (10.0) | 1 (6.7) | 2 (8.0) |
| Prior treatment, median (range) | |||
| No. regimens | 1 (1-4) | 2 (1-5) | 2 (1-5) |
| Mo./no. cycles of treatment | 4 (3-15) | 9 (4-25) | 7 (3-25) |